In mouse models of atherosclerosis, selective removal of p16-expressing senescent cells or senolytic treatments improved plaque burden in the aorta, suggesting that senescent cells participate in key aspects of atherosclerosis (40, 52–54). This evidence concerns the gene CDKN2A and atherosclerosis.